Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Lamotrigine =
- Therapeutic area
- CNS & mental health
- Drug class
- Antiepileptics
- ATC
- N03
- Strength
- 25 mg
- Dosage form
- Tablet
- Pack
- 30's
- Registration no.
- 105401
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-10-09 03:22
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Trignine 25 mg tablet
Trignine 25 mg tablet contains Lamotrigine = 25 mg. It is registered with DRAP by HIGH-Q Pharmaceuticals (registration no. 105401). Its official price is PKR 618.14 for a pack of 30's, about PKR 20.60 per tablet. This price has applied since 18 August 2025. Trignine is also available as 100 mg tablet and 50 mg tablet. 20 other brands of Lamotrigine = 25 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Other strengths of Trignine
Other brands of Lamotrigine = 25 mg
Official price over time
No change in the official DRAP price is recorded for this pack (30's). Current price PKR 618.14, effective 18 Aug 2025.
Cite this price history
MedInfoBase. Trignine 25 mg, 30's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/trignine-25-mg-105401-30s-high-q-pharmaceuticals/ (accessed 9 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 618.14 | 2025-08-18 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 105401Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.
